CELL SIGNALING TECHNOLOGY INC.

Company Overview

Cell Signaling Technology (CST) is founded by research scientists in 1999, as a private, family-owned company that provides high quality research antibodies and other life science research tools. CST is active in the field of business segment of applied systems biology research, which is used in research purpose of cancer. CST knows the importance of using antibodies during research with high levels of specificity. The CST scientists who produce its antibodies, provides technical support to customers for designing the experiments, troubleshoot and to achieve the known results. CST aims to deliver the highest quality research, diagnosis information and therapeutic products to accelerate biological understanding about personalized medicine.

Company's Business Segments

• Products : Primary Antibodies, Secondary Antibodies, Antibody Samplers, Antibody Conjugates, ELISA Kits, Cellular Assay Kits, Proteomic Analysis Products, WB and IP Reagents, SignalStar Multiplex IHC Kits and Reagents, CUT&RUN Kits and Reagents, CUT&Tag Kits and Reagents, ChIP Kits and Reagents, Flow Cytometry Kits and Reagents, Recombinant Proteins ,siRNA, Cytokines and Growth Factors, Activators and Inhibitors, Buffers and Dyes, BSA and Azide Free.
• Services : Carrier-free custom Antibody Formulations, AQUA and Custom Blocking Peptides, Proteomics Analytical Services, Custom Conjugation and Labeling Services, Bulk Quantities and Lot Reservations.